References
- BabjukMBöhleABurgerMGuidelines on Non-Muscle-Invasive Bladder Cancer (Ta, T1 and CIS)Arnhem, The NetherlandsEuropean Association of Urology2016
- LiedbergFHagbergOHolmängSLocal recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up studyScand J Urol201549429029525624049
- HermannGGMogensenKLindvoldLRHaakCSHaedersdalMOffice-based transurethral devascularisation of low grade non-invasive urothelial cancer using diode laser. A feasibility studyLasers Surg Med201547862062526373344
- HermannGGMogensenKToftBGGlenthøjAPedersenHMOutpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsiesScand J Urol Nephrol2012461313622150596
- YeungCDinhTLeeJThe health economics of bladder cancer: an updated review of the published literaturePharmacoeconomics201432111093110425056838
- YoshimuraKUtsunomiyaNIchiokaKMatsuiYTeraiAAraiYImpact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 surveyUrology200565229029415708040
- MogensenKChristensenKBVrangMLHermannGGHospitalization for transurethral bladder resection reduces quality of life in Danish patients with non-muscle-invasive bladder tumourScand J Urol201650317017426817989
- DaneshmandSPatelSLotanYFlexible Blue Light Study Group CollaboratorsEfficacy and safety of blue light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: a phase III, comparative, multicenter studyJ Urol201819951158116529203268
- BurgerMGrossmanHBDrollerMPhotodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystos-copy: a meta-analysis of detection and recurrence based on raw dataEur Urol201364584685423602406
- WitjesJABabjukMGonteroPClinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendationsEur Urol201466586387125001887
- DaneshmandSSchuckmanAKBochnerBHHexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USANat Rev Urol2014111058959625245244
- MalmströmPUGrabeMHaugESRole of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidanceScand J Urol Nephrol201246210811622087730
- WitjesJAMoonenPMvan der HeijdenAGComparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective phase II studyEur Urol200547331932215716194
- LoidlWSchmidbauerJSusaniMMarbergerMFlexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?Eur Urol200547332332615716195
- WongKAZisengweGAthanasiouTO’BrienTThomasKOutpatient laser ablation of non-muscle-invasive bladder cancer: is it safe, tolerable and cost-effective?BJU Int2013112556156723819486
- BertrandJSoustelleLGrèsPIntérêt de la vidéocystoscopie souple en lumière bleue (+Hexvix®) en consultation pour le diagnostic des tumeurs de vessie [Interest of flexible videocystoscopy in blue light (+Hexvix®) in consultation for the diagnosis of vesical tumor]Prog Urol2012223172177 French22364628
- KarlAWeidlichPBuchnerAPhotodynamic diagnosis of the urinary bladder using flexible instruments – ready for the outpatient setting?J Clin Trials20144190
- LindvoldLRHermannGGAn optical method for reducing green fluorescence from urine during fluorescence-guided cystoscopyMethods Appl Fluoresc20164404500228192305
- MariappanPRaiBEl-MokademIReal-life experience: early recurrence with Hexvix photodynamic diagnosis–assisted transurethral resection of bladder tumour vs good-quality white light TURBT in new non-muscle-invasive bladder cancerUrology201586232733126142924
- DanskVMalmströmPUBläckbergMMalmenäsMHexaminolevulinate hydrochloride blue-light flexible cystoscopy in the detection and follow-up of nonmuscle-invasive bladder cancer: cost consequences during outpatient surveillance in SwedenFuture Oncol20161281025103826975197